Abstract 362P
Background
Continuity of care is an important domain of provision of Palliative services. Round the clock Consultation liaison services are provided to all registered Patients (through an on-call number manned by the Resident on call). The Investigator's phone number is bieng provided upon Patient request. Advice regarding symptomatic management (including titration of analgesia), counseling regarding goals of care and opportunity to facilitate a liaison with the Patient's Local physician are bieng provided via telephonic consult. Text messages also form a frequent means of providing important treatment related information.
Methods
29 patients who had contacted this Resident during a period extending from November 2017 to May 2019 were invited to take part in an Investigator initiated Telephonic survey.
Results
11 respondents who were also primary caregivers agreed to participate. The remainder either were unreachable or declined to participate. 5/11 respondents had contacted the on call number while 7/11 had contacted the Investigator's number more than twice. 4/7 were satisfied with the response that they received on the on call number. 2 out of 10 respondents had used the number facilitating a liaison between the Resident and Local Physician. There was unanimous agreement on the feasibility and appropriateness of the on call liaison for provision of Bereavement services. There was consensus that the gender of the Resident did not affect Patient preferences. All respondents agreed that the text message had been an important means of disseminating information. Difficult to control pain was identified as the leading indication for seeking a Telephonic liaison. 3/11 respondents opined that the on-call number should be more accessible. 5/7 respondents agreed that they could have been provided better end of life care. Pain, reduced oral intake and constipation were identified as symptoms that caused the maximum amount of concern during the terminal phase of decline. Two caregivers used the opportunity to air grievances about quality of patient care services that they were provided.
Conclusions
Telephonic liaison services have the potential to act as an effective mode of delivery of palliative (including end of life care) services.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Dr. Rahul D. Arora, Senior Resident, Dept. of Palliative Medicine, All India Institute of Medical Scinces, New Delhi, India.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
258P - Assessment of sexual health in patients treated for ovarian cancer
Presenter: Renu Madan
Session: Poster display session
Resources:
Abstract
259P - The BOT patients fail to benefit from surgical staging procedures in prognosis and fertility outcomes: A retrospective analysis
Presenter: Li Na
Session: Poster display session
Resources:
Abstract
260P - Malignant ovarian germ cell tumours (MOGCT): Treatment results of 149 pts
Presenter: Dzhennet Chekini
Session: Poster display session
Resources:
Abstract
261P - Ovarian germ cell tumours - challenges and outcomes from a tertiary care centre in South India
Presenter: Vishnu Sreedath
Session: Poster display session
Resources:
Abstract
262P - Gestational trophoblastic tumours: Experience of the medical oncology department Hassan II University Hospital-Morocco about 29 cases
Presenter: Karima Oualla
Session: Poster display session
Resources:
Abstract
263TiP - ATHENA (GOG-3020/ENGOT-ov45): A randomised, double-blind, placebo-controlled phase III study of the poly (ADP-ribose) polymerase (PARP) inhibitor rucaparib + the PD-1 inhibitor nivolumab following frontline platinum-based chemotherapy in ovarian cancer
Presenter: Keiichi Fujiwara
Session: Poster display session
Resources:
Abstract
264TiP - ENGOT-ov43/KEYLYNK-001: A phase III trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of BRCA¬-nonmutated advanced epithelial ovarian cancer
Presenter: Keiichi Fujiwara
Session: Poster display session
Resources:
Abstract
265TiP - KEYNOTE-826: A phase III randomized study of chemotherapy with or without pembrolizumab for first-line treatment of persistent, recurrent, or metastatic cervical cancer
Presenter: Keiichi Fujiwara
Session: Poster display session
Resources:
Abstract
271P - Comparison between CHOP like regimens and DAEPOCH with or without Rituximab in adult high grade B cell lymphoma NOS; A retrospective study from a tertiary cancer hospital in South India
Presenter: LALATENDU MOHARANA
Session: Poster display session
Resources:
Abstract
272P - Melatonin increases the chemosensitivity of diffuse large Bell lymphoma cells to Epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway
Presenter: Xiuhua Sun
Session: Poster display session
Resources:
Abstract